Skip to main content
. 2023 Mar 2;23:197. doi: 10.1186/s12885-023-10670-3

Table 1.

Baseline characteristics of the dataset

Characteristics n (%) Patient count or mean % or SD
(n = 3352)
Gender, n (%)
 Female 708 21.1%
 Male 2644 78.9%
 Age (mean, years) 61.24 7.77
 BMI (mean, kg/m2) 22.86 2.71
 Smokers, n (%) 2156 64.3%
 Alcohol, n (%) 2057 61.4%
 Family history of cancer, n (%) 816 24.3%
 Family history of ESCC, n (%) 531 15.8%
Tumor location, n (%)
 upper 319 9.5%
 middle 2176 64.9%
 lower 857 25.6%
Pathologic T stage, n (%)
 Tis 44 1.3%
 T1a 201 6.0%
 T1b 801 23.9%
 T2 1192 35.6%
 T3 1103 32.9%
 T4a 11 0.3%
Tumor grade, n (%)
 Gx 51 1.5%
 G1 292 8.7%
 G2 2062 61.5%
 G3 947 28.3%
 Tumor size (mean ± SD, cm) 3 1.5
Pathologic N stage, n (%)
N0 1833 54.7%
N1 906 27.0%
N2 441 13.2%
N3 172 5.1%
Thoracic LN, n (%)
 Positive 748 22.3%
 Negative 2604 77.7%
Abdomen LN, n (%)
 Positive 755 22.5%
 Negative 2597 77.5%
Pathology-confirmed RLN LN, n (%)
 Left 3249
 Positive 351 10.8%
 Negative 2898 89.2%
 Right 3344
 Positive 569 17.0%
 Negative 2775 83.0%

SD standard deviation, BMI body mass index, ESCC esophageal squamous cell carcinoma, LN lymph node, RLN recurrent laryngeal nerve